8-Bromo-1-(1,3-dimethyl-1H-pyrazol-4-yl)-3-methyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-one → HCID 59619647, compound

HRID 445655Notes

Reaction equation

HRID 445655 reaction equation
Br[C:2]1[CH:11]=[CH:10][C:9]2[N:8]=[CH:7][C:6]3[N:12]([CH3:23])[C:13](=[O:22])[N:14]([C:15]4[C:16]([CH3:21])=[N:17][N:18]([CH3:20])[CH:19]=4)[C:5]=3[C:4]=2[CH:3]=1.[CH2:24]([N:26]([CH2:42][CH3:43])[C:27]1[CH:28]=[N:29][CH:30]=[C:31](B2OC(C)(C)C(C)(C)O2)[CH:32]=1)[CH3:25]>>[CH2:42]([N:26]([CH2:24][CH3:25])[C:27]1[CH:32]=[C:31]([C:2]2[CH:11]=[CH:10][C:9]3[N:8]=[CH:7][C:6]4[N:12]([CH3:23])[C:13](=[O:22])[N:14]([C:15]5[C:16]([CH3:21])=[N:17][N:18]([CH3:20])[CH:19]=5)[C:5]=4[C:4]=3[CH:3]=2)[CH:30]=[N:29][CH:28]=1)[CH3:43]

Participants

3

Procedure

The title compound was synthesized in a similar manner as described for Example 1.1 using 8-bromo-1-(1,3-dimethyl-1H-pyrazol-4-yl)-3-methyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-one (Intermediate A) and diethyl-[5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-3-yl]-amine (Stage 95.1.1) to give the title compound as a white solid. (HPLC: tR 2.31 min (Method A); M+H=442 MS-ES; 1H-NMR (d6-DMSO, 400 MHz) 8.98 (s, 1H), 8.13-8.09 (m, 2H), 8.07-8.05 (m, 1H), 7.96-7.91 (m, 2H), 7.60-7.58 (m, 1H), 6.95-6.92 (m, 1H), 3.87 (s, 3H), 3.58 (s, 3H), 3.46-3.39 (m, 4H), 1.97 (s, 3H), 1.13 (t, 6H))

Workup

  1. customThe title compound was synthesized in a similar manner

Sources & evidence

ORD record
ord-fe3c6ff814a445e6b9a5c3b97a9c4859
Source dataset
uspto-grants-2013_07
Patent number
US08476294B2

Reaction notes

Loading…